Nonoperating Income (Expense) in USD of Upstream Bio, Inc. from Q3 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Upstream Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q3 2023 to Q3 2025.
  • Upstream Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $4.09M, a 40.8% increase year-over-year.
  • Upstream Bio, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $18.3M.
  • Upstream Bio, Inc. annual Nonoperating Income (Expense) for 2024 was $15M, a 23.6% decline from 2023.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Upstream Bio, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $18.3M $4.09M +$1.19M +40.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $17.1M $4.38M +$1.52M +53.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $15.6M $4.74M +$624K +15.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $15M $5.08M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-12
Q3 2024 $2.9M -$3.38M -53.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $2.86M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $4.12M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q3 2023 $6.28M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07

Upstream Bio, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $15M -$4.62M -23.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-12
2023 $19.6M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.